Login / Signup

New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.

Paul S HaberBenjamin C RiordanDaniel T WinterLiz BarrettJohn SaundersLeanne HidesMatthew GulloVictoria ManningCarolyn A DayYvonne BonomoLucinda BurnsRobert AssanKen CurryJulie Mooney-SomersApo DemirkolLauren MondsMike McDonoughAndrew J BailliePaul ClarkAlison RitterCatherine QuinnJohn CunninghamNicholas LintzerisSusan RomboutsMichael SavicAmanda NormanSharon ReidDelyse HutchinsonCatherine ZhengYasmine IeseNicola BlackBrian DraperNicole RidleyLinda GowingLexine StapinskiBelaynew TayeKari LancasterDaniel StjepanovićFrances Kay-LambkinNazila JamshidiDan LubmanAdam PastorNatalie WhiteScott WilsonAlison L JaworskiSonja MemedovicWarren LoggeKatherine MillsKate SeearBradley FreeburnToby LeaAdrienne WithallChristina MarelJohn BoffaAmanda RoxburghGemma Purcell-KhodrMichael DoyleKate ConigraveMaree TeessonKerryn ButlerJason ConnorKirsten C Morley
Published in: The Medical journal of Australia (2021)
Chapter 5: Understanding and managing comorbidities for people with alcohol problems: polydrug use and dependence, co-occurring mental disorders, and physical comorbidities Polydrug use and dependence Active alcohol use disorder, including dependence, significantly increases the risk of overdose associated with the administration of opioid drugs. Specialist advice is recommended before treatment of people dependent on both alcohol and opioid drugs (GPP). Older patients requiring management of alcohol withdrawal should have their use of pharmaceutical medications reviewed, given the prevalence of polypharmacy in this age group (GPP). Smoking cessation can be undertaken in patients with alcohol dependence and/or polydrug use problems; some evidence suggests varenicline may help support reduction of both tobacco and alcohol consumption (Level C). Co-occurring mental disorders More intensive interventions are needed for people with comorbid conditions, as this population tends to have more severe problems and carries a worse prognosis than those with single pathology (GPP). The Kessler Psychological Distress Scale (K10 or K6) is recommended for screening for comorbid mental disorders in people presenting for alcohol use disorders (Level A). People with alcohol use disorder and comorbid mental disorders should be offered treatment for both disorders; care should be taken to coordinate intervention (Level C). Physical comorbidities Patients should be advised that alcohol use has no beneficial health effects. There is no clear risk-free threshold for alcohol intake. The safe dose for alcohol intake is dependent on many factors such as underlying liver disease, comorbidities, age and sex (Level A). In patients with alcohol use disorder, early recognition of the risk for liver cirrhosis is critical. Patients with cirrhosis should abstain from alcohol and should be offered referral to a hepatologist for liver disease management and to an addiction physician for management of alcohol use disorder (Level A). Alcohol abstinence reduces the risk of cancer and improves outcomes after a diagnosis of cancer (Level A).
Keyphrases